DIALOG SEMICONDUCTOR Plc.
- WKN: 927200
- ISIN: GB0059822006
- Land: United Kingdom
Nachricht vom 12.10.2021 | 11:00
REGULATORY ANNOUNCEMENT FOLLOWING THE END OF THE BREXIT TRANSITION PERIOD
DGAP-News: Dialog Semiconductor Plc.
/ Key word(s): Miscellaneous
London - 12 October 2021. Dialog Semiconductor Limited (formerly Dialog Semiconductor Plc) ("Dialog"), today announced that it supplements its announcement of 4 January 2021 in respect of the choice of the Federal Republic of Germany (Germany) as its EU home member state for purpose of the EU-Transparency Directive as follows:
Dialog commits (i) to publish Dialog's single-entity financial statements including an income statement for the financial year ended on 31 December 2020 prepared in accordance with
This announcement is solely made to comply with the financial reporting obligations pursuant to Sec. 114 et seqq. German Securities Trading Act applicable to Dialog's annual financial report for the year ended on 31 December 2020 and its half-yearly financial report for the period ended on
The corporate headquarters of Dialog remains located in Reading, United Kingdom.
Dialog and the Dialog logo are trademarks of Dialog Semiconductor Limited or its subsidiaries. All other product or service names are the property of their respective owners. (c) Copyright 2021 Dialog Semiconductor. All rights reserved.
|Company:||Dialog Semiconductor Plc.|
|Tower Bridge House, St. Katharine's Way|
|E1W 1AA London|
|Phone:||+49 7021 805-412|
|Fax:||+49 7021 805-200|
|Listed:||Foreign Exchange(s) London|
|EQS News ID:||1240011|
|End of News||DGAP News Service|
GBC im Fokus
IGEA Pharma N.V. Realignment to CBD extraction
The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.
Der AKTIONÄR News
04. Dezember 07:15 Bitcoin & Co: Brutaler Abverkauf – ist die Party jetzt vorbei?
04. Dezember 08:00 Top-Tipp Derivate: Luxus in der Warteschleife
04. Dezember 08:05 China-Aktien, Bitcoin & Co: Risiko-Assets werden verkauft
04. Dezember 08:45 Deutsche Telekom: 50 Prozent Potenzial - wann gelingt die Trendwende?
05. Dezember 07:00 Diese Token sind heißer als Bitcoin
News im Fokus
Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an
03. Dezember 2021, 07:03
FY 2020/2021 Financial Results
16. Dezember 2021
Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen
02. Dezember 2021